Clinical Trials Browser

Observational × Alpelisib × 90 days × Clear all

NCT05022342 2026-02-23

SPEAR

Breast Neoplasms

NCT06083038 2025-12-31

Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

Active not recruiting

Breast Neoplasms, Hyperglycemia